Lactobacillus acidophilus ATCC 4356 Prevents Atherosclerosis via Inhibition of Intestinal Cholesterol Absorption in Apolipoprotein E-Knockout Mice
- 2014-12-15
- Clinical Trial
- Applied and Environmental Microbiology 80(24)
- Ying Huang
- Jinfeng Wang
- Guihua Quan
- Xiaojun Wang
- Longfei Yang
- Lili Zhong
- PubMed: 25261526
- DOI: 10.1128/AEM.02926-14
- Low evidence
- Highly Cited
- Animal Study
- Clinical
suppression of cholesterol absorption induced reverse cholesterol transport (RCT) in macrophages through the peroxisome proliferator-activated receptor/liver X receptor (PPAR/LXR) pathway.
- Effect
- Beneficial
- Effect size
- Moderate